The two main incretins involved in this process are glucagon-like peptide-1 (GLP-1) and glucose-dependent ... effects when stopping these medications should be discussed with the patients.

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug for weight management. The Food and Drug Administration’s approval ...

Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...

Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA ... left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and ...

Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting ... which greatly influences manufacturing and drug product development. This work provides a ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

A Comprehensive, Evidence-Based Review of GLP-1/GIP Agonists for Fitness and Wellness Professionals ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...